This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rothfuss, A. Articles by Speit, G. Search for Related Content PubMed PubMed Citation Articles by Rothfuss, A. Articles by Speit, G.

Induced Micronucleus Frequencies in Peripheral Lymphocytes as a Screening Test for Carriers of a BRCA1 Mutation in Breast Cancer Families¹

Universitätsklinikum Ulm, Abt. Medizinische Genetik, D-89070 Ulm [A. R., P. S., S. B., W. V., G. S.], and Universitäts-Frauenklinik, D-89070 Ulm [T. V., E. E., R. K.], Germany

Enhanced sensitivity to the chromosome-damaging effects of ionizing radiation is a feature of many cancer-predisposing conditions. It has been suggested that women with breast cancer are deficient in the repair of radiation-induced DNA damage. We have now investigated whether mutagen sensitivity is related to mutations in the breast cancer gene BRCA1. We studied the induction and repair of DNA damage in lymphocytes of women from families with familial breast cancer and breast and ovarian cancer. The mutagens used were gamma-irradiation and hydrogen peroxide and the DNA effects were determined with the micronucleus test and the comet assay. Women with a BRCA1 mutation (n = 12) and relatives without the familial mutation (n = 10) were compared to controls (i.e., healthy women without family history of breast or ovarian cancer; n = 17). Our results indicate a close relationship between the presence of a BRCA1 mutation and sensitivity for the induction of micronuclei. Compared to a concurrent control, 10 of 11 women with a BRCA1 mutation showed elevated radiation sensitivity. Of the 10 related women without the familial mutation, only 2 had clearly enhanced micronucleus frequencies. In addition to the sensitivity toward gamma-irradiation, hypersensitivity toward hydrogen peroxide was also observed, indicating that the mutagen sensitivity is not solely due to a defect in the repair of DNA double strand breaks. In contrast to the results with the micronucleus assay, we found no significant difference between women with and without a BRCA1 mutation with respect to the induction and repair of DNA damage in the comet assay. This finding suggests a normal rate of damage removal and points to a disturbed fidelity of DNA repair as a direct or indirect consequence of a BRCA1 mutation. Our results support the usefulness of induced micronucleus frequencies as a biomarker for cancer predisposition and suggest its application as a screening test for carriers of a BRCA1 mutation in breast cancer families.

This article has been cited by other articles:

				N. Kopjar, I. Milas, V. Garaj-Vrhovac, and M. Gamulin Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients Human and Experimental Toxicology, May 1, 2007; 26(5): 391 - 399. [Abstract] [PDF]

				D. Varga, J. Hoegel, C. Maier, S. Jainta, M. Hoehne, B. Patino-Garcia, I. Michel, U. Schwarz-Boeger, M. Kiechle, R. Kreienberg, et al. On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls Mutagenesis, September 1, 2006; 21(5): 313 - 320. [Abstract] [Full Text] [PDF]

				N. Andrieu, D. F. Easton, J. Chang-Claude, M. A. Rookus, R. Brohet, E. Cardis, A. C. Antoniou, T. Wagner, J. Simard, G. Evans, et al. Effect of Chest X-Rays on the Risk of Breast Cancer Among BRCA1/2 Mutation Carriers in the International BRCA1/2 Carrier Cohort Study: A Report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group J. Clin. Oncol., July 20, 2006; 24(21): 3361 - 3366. [Abstract] [Full Text] [PDF]

				R. A. El-Zein, M. B. Schabath, C. J. Etzel, M. S. Lopez, J. D. Franklin, and M. R. Spitz Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res., June 15, 2006; 66(12): 6449 - 6456. [Abstract] [Full Text] [PDF]

				B. Patino-Garcia, J. Hoegel, D. Varga, M. Hoehne, I. Michel, S. Jainta, R. Kreienberg, C. Maier, and W. Vogel Scoring variability of micronuclei in binucleated human lymphocytes in a case-control study Mutagenesis, May 1, 2006; 21(3): 191 - 197. [Abstract] [Full Text] [PDF]

				C. E. Jacobi, N. J.D. Nagelkerke, J. C. van Houwelingen, and G. H. de Bock Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 429 - 436. [Abstract] [Full Text] [PDF]

				S. Beetstra, C. Salisbury, J. Turner, M. Altree, R. McKinnon, G. Suthers, and M. Fenech Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency Carcinogenesis, March 1, 2006; 27(3): 517 - 524. [Abstract] [Full Text] [PDF]

				X. Wang, X. Wu, Z. Liang, Y. Huang, M. Fenech, and J. Xue A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan Mutagenesis, January 1, 2006; 21(1): 41 - 47. [Abstract] [Full Text] [PDF]

				I. Hilger, A. Rapp, K.-O. Greulich, and W. A. Kaiser Assessment of DNA Damage in Target Tumor Cells after Thermoablation in Mice Radiology, November 1, 2005; 237(2): 500 - 506. [Abstract] [Full Text] [PDF]

				C. Bolognesi, F. Martini, M. Tognon, R. Filiberti, M. Neri, E. Perrone, E. Landini, P. A. Canessa, G. P. Ivaldi, P. Betta, et al. A Molecular Epidemiology Case Control Study on Pleural Malignant Mesothelioma Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1741 - 1746. [Abstract] [Full Text] [PDF]

				M. Fenech The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis Mutagenesis, July 1, 2005; 20(4): 255 - 269. [Abstract] [Full Text] [PDF]

				K. Trenz, P. Schutz, and G. Speit Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis Mutagenesis, March 1, 2005; 20(2): 131 - 137. [Abstract] [Full Text] [PDF]

				D. Varga, T. Johannes, S. Jainta, S. Schuster, U. Schwarz-Boeger, M. Kiechle, B. P. Garcia, and W. Vogel An automated scoring procedure for the micronucleus test by image analysis Mutagenesis, September 1, 2004; 19(5): 391 - 397. [Abstract] [Full Text] [PDF]

				A. Rothfuss and M. Grompe Repair Kinetics of Genomic Interstrand DNA Cross-Links: Evidence for DNA Double-Strand Break-Dependent Activation of the Fanconi Anemia/BRCA Pathway Mol. Cell. Biol., January 1, 2004; 24(1): 123 - 134. [Abstract] [Full Text] [PDF]

				D. J. Brenner, R. Doll, D. T. Goodhead, E. J. Hall, C. E. Land, J. B. Little, J. H. Lubin, D. L. Preston, R. J. Preston, J. S. Puskin, et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know PNAS, November 25, 2003; 100(24): 13761 - 13766. [Abstract] [Full Text] [PDF]

				P. Thomas, K. Umegaki, and M. Fenech Nucleoplasmic bridges are a sensitive measure of chromosome rearrangement in the cytokinesis-block micronucleus assay Mutagenesis, March 1, 2003; 18(2): 187 - 194. [Abstract] [Full Text] [PDF]

				S. M. Ginolhac, S. Gad, M. Corbex, B. Bressac-de-Paillerets, A. Chompret, Y.-J. Bignon, J.-P. Peyrat, J. Fournier, C. Lasset, S. Giraud, et al. BRCA1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA1 Germ-Line Mutations Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 90 - 95. [Abstract] [Full Text] [PDF]

				C. Bolognesi, R. Filiberti, M. Neri, E. Perrone, E. Landini, P. A. Canessa, C. Simonassi, P. G. Cerrano, L. Mutti, and R. Puntoni High Frequency of Micronuclei in Peripheral Blood Lymphocytes as Index of Susceptibility to Pleural Malignant Mesothelioma Cancer Res., October 1, 2002; 62(19): 5418 - 5419. [Abstract] [Full Text] [PDF]

				P. Xiong, M. L. Bondy, D. Li, H. Shen, L.-E Wang, S. E. Singletary, M. R. Spitz, and Q. Wei Sensitivity to Benzo(a)pyrene Diol-Epoxide Associated with Risk of Breast Cancer in Young Women and Modulation by Glutathione S-Transferase Polymorphisms: A Case-Control Study Cancer Res., December 1, 2001; 61(23): 8465 - 8469. [Abstract] [Full Text] [PDF]

				M. G. Andreassi, E. Picano, S. Del Ry, N. Botto, M. G. Colombo, D. Giannessi, V. Lubrano, C. Vassalle, and A. Biagini Chronic long-term nitrate therapy: possible cytogenetic effect in humans? Mutagenesis, November 1, 2001; 16(6): 517 - 521. [Abstract] [Full Text] [PDF]

				K. Baria, C. Warren, S. A. Roberts, C. M. L. West, D. G. R. Evans, J. M. Varley, and D. Scott Correspondence re: A. Rothfuss et al., Induced micronucleus frequencies in peripheral blood lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res., 60: 390-394, 2000. Cancer Res., August 1, 2001; 61(15): 5948 - 5949. [Full Text] [PDF]